Skip to main content
OpenTrials

Clinical trial condition

Retinitis Pigmentosa

Explore clinical trials studying Retinitis Pigmentosa. Study availability and eligibility vary by location and protocol.

199 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Retinitis Pigmentosa trial results

Completed

The FIGHT-RP1 Study

NCT03063021

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Wilmer Eye Institute, Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Retrospective NIS to Evaluate the Patient Benefit of TES

NCT04983914

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Universitätsklinikum Heidelberg, Augenklinik Heidelberg, Germany
  • Klinikum Stuttgart gKAöR, Augenklinik Standort Mitte (Katharinenhospital) Stuttgart, Germany
  • Universitäts-Augenklinik Tübingen, Abt. für Augenheilkunde Tübingen, Germany
  • Universitätsspital Basel, Augenklinik Basel, Switzerland
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

NCT03780257

Conditions
Abnormalities, Multiple, Blindness, Congenital Abnormalities, +27 more
Locations
  • Center for Clinical Research Operations, Massachusetts Eye and Ear Boston, Massachusetts, United States
  • University of Michigan, Kellogg Eye Center Ann Arbor, Michigan, United States
  • Casey Eye Institute, Oregon Health & Science University Portland, Oregon, United States
  • Retina Foundation of the Southwest Dallas, Texas, United States
View Trial Details
Completed

Argus® II Retinal Stimulation System Feasibility Protocol

NCT00407602

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Doheny Eye Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Johns Hopkins, Wilmer Eye Institute Baltimore, Maryland, United States
  • Columbia University, Department of Ophthalmology, Edward S. Harkness Eye Institute New York, United States
View Trial Details

Related conditions